Pharma maker pulls weight loss drug over FDA concerns
Eisai disagrees with FDA decision.
Read more
 
FDA clears first-in-class high cholesterol drug
The treatment is the first non-statin LDL-C lowering med approved in years.
Read more
 
EDITOR'S PICK
Epilepsy, bipolar drug recalled due to contamination
Taro Pharmaceuticals is voluntarily recalling the med for bipolar disorder and seizures after cross-contamination with a heart drug.
Read more